RecallDepth
Class I Terminated

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Company
Gilead Sciences, Inc.
Recall Initiated
December 3, 2021
Posted
January 5, 2022
Recall Number
D-0299-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
53,473 vials
Firm Location
Foster City, CA, United States

Reason for Recall

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Distribution

Nationwide in the USA

Lot / Code Info

Lots: 2141001-1A, 2141002-1A, Exp. 01/2024

More recalls by Gilead Sciences, Inc.

View all recalls by this company →

Other recent Class I Drug recalls